22 results
Systemic Lupus Erythematosus (SLE) - Diagnosis and Management Summary
 • Epidemiology: 10-180/100,000, Typically Age 20-40, F:M
Diagnosis and Management ... 40, F:M 9:1 • Clinical ... Photosensitivity, Alopecia ... Usual therapeutic management ... Erythematosus #Diagnosis #Management
A quick infographic describing some of the common reversal agents used by anesthesiologists, their mechanism of
common reversal agents ... #management #anesthesia ... anaesthesia and critical ... Pharmacology of ... neuromuscular pharmacology
Drug Induced Lupus vs SLE
Drug Induced Lupus (DIL):
 • Epidemiology: -10% of all lupus cases, drug-dependent,
to 1:1 F:M • Clinical ... 40, F:M 9:1 • Clinical ... Photosensitivity, Alopecia ... Usual therapeutic management ... rheumatology #diagnosis #management
Anti-IL6 Agents (Tocilizumab, Siltuximab) in COVID19

IL-6 activates T cells and macrophages, among other cell types (see
Anti-IL6 Agents ... other cell types (see ... Siltuximab #COVID19 #Pharmacology ... #Management #Medications
Pain, Agitation, and Delirium (PAD) in the ICU
Addressing the ICU Triad (PAD) can be accomplished through
will vary with clinical ... non-OTC prolonging agent ... No pharmacologic ... (Haldol) - No pharmacologic ... CriticalCare #diagnosis #management
Allergic Bronchopulmonary Aspergillosis (ABPA)
WHAT IS IT?
Hypersensitivity response to Aspergillus fumigatus in the airways
 • Primarily affects
WHAT ARE THE CLINICAL ... WHAT CAN YOU SEE ... with an azole agent ... steroid sparing agent ... pulmonary #diagnosis #management
Sexually Transmitted Infections - Common Outpatient Treatments 
Chlamydia 
 - Azithromycin 1 g PO once
primary care, we see ... recommendations for other agents ... Outpatient #Treatment #Management ... #Pharmacology
COPD Management Algorithm - GOLD 2019 guidelines 

Categorize into COPD GOLD A-D -> Initiate first-line therapy
COPD Management ... as a first-line agent ... See one of my previous ... GOLD2019 #Guidelines #Management ... Pulmonary #Algorithm #pharmacology
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
IDSA - Clinical ... these injectable agents ... over injectable agents ... Tuberculosis #MDRTB #management ... antimicrobials #regimens #pharmacology
Black Hairy Tongue- ...A polymicrobial wound infection developed, and she received treatment with intravenous meropenem and
developed, and she ... of antibiotic agents ... precipitating agent ... #NEJM #photo #clinical